Cargando…

The antimalarial ferroquine: from bench to clinic

Ferroquine (FQ, SSR97193) is currently the most advanced organometallic drug candidate and about to complete phase II clinical trials as a treatment for uncomplicated malaria. This ferrocenecontaining compound is active against both chloroquine-susceptible and chloroquine-resistant Plasmodium falcip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biot, C., Nosten, F., Fraisse, L., Ter-Minassian, D., Khalife, J., Dive, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	EDP Sciences 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671469/ https://www.ncbi.nlm.nih.gov/pubmed/21894260 http://dx.doi.org/10.1051/parasite/2011183207

Ejemplares similares

Ferroquine, an Ingenious Antimalarial Drug –Thoughts on the Mechanism of Action
por: Dubar, Faustine, et al.
Publicado: (2008)

Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure
por: Daher, Wassim, et al.
Publicado: (2006)

Ferroquine, the next generation antimalarial drug, has antitumor activity
por: Kondratskyi, Artem, et al.
Publicado: (2017)

Ferroquine and its derivatives: New generation of antimalarial agents
por: Wani, Waseem A., et al.
Publicado: (2015)

In vitro and in vivo antischistosomal activity of ferroquine derivatives
por: Keiser, Jennifer, et al.
Publicado: (2014)

Lipid Compositions in Infant Formulas Affect the Solubilization of Antimalarial Drugs Artefenomel (OZ439) and Ferroquine during Digestion
por: Salim, Malinda, et al.
Publicado: (2020)

In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border
por: Barends, Marion, et al.
Publicado: (2007)

Investigations on the Novel Antimalarial Ferroquine in Biomimetic Solutions Using Deep UV Resonance Raman Spectroscopy and Density Functional Theory
por: Domes, Robert, et al.
Publicado: (2023)

A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study
por: McCarthy, James S., et al.
Publicado: (2016)

Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection
por: Mombo-Ngoma, Ghyslain, et al.
Publicado: (2011)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

Impact of Ferroquine on the Solubilization of Artefenomel (OZ439) during in Vitro Lipolysis in Milk and Implications for Oral Combination Therapy for Malaria
por: Salim, Malinda, et al.
Publicado: (2019)

Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate
por: Wein, S, et al.
Publicado: (2012)

From bench to clinic
por: Agarwal, Ashok, et al.
Publicado: (2017)

Current hurdles to the translation of nanomedicines from bench to the clinic
por: Đorđević, Snežana, et al.
Publicado: (2021)

Parkinson's Disease in India: From Clinic to Bench
por: Tan, Louis C. S., et al.
Publicado: (2020)

Rosetting Responses of Plasmodium-infected Erythrocytes to Antimalarials
por: Lee, Wenn-Chyau, et al.
Publicado: (2022)

Acridine-Based Antimalarials—From the Very First Synthetic Antimalarial to Recent Developments
por: Fonte, Mélanie, et al.
Publicado: (2021)

Radioprotection and Radiomitigation: From the Bench to Clinical Practice
por: Obrador, Elena, et al.
Publicado: (2020)

Liquid biopsies for cancer: From bench to clinic
por: Chen, Zhenhui, et al.
Publicado: (2023)

Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic
por: Kadam, Shilpa D., et al.
Publicado: (2019)

Bench-to-bedside review: Clinical experience with the endotoxin activity assay
por: Romaschin, Alexander D, et al.
Publicado: (2012)

Clinical utility of asthma biomarkers: from bench to bedside
por: Vijverberg, Susanne JH, et al.
Publicado: (2013)

Marine Antimalarials
por: Fattorusso, Ernesto, et al.
Publicado: (2009)

Bioorganometallic Chemistry and Malaria
por: Biot, Christophe, et al.
Publicado: (2010)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria
por: Gansane, Adama, et al.
Publicado: (2023)

Cancer proteomics: from bench to bedside
por: Timms, J F
Publicado: (2008)

Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine
por: Permala, Jesmin, et al.
Publicado: (2017)

Modelling Pancreatic Neuroendocrine Cancer: From Bench Side to Clinic
por: Ney, Alexander, et al.
Publicado: (2020)

Drug addiction: from bench to bedside
por: Cheron, Julian, et al.
Publicado: (2021)

Molecular Imaging: From Bench to Clinic
por: Wáng, Yì-Xiáng J., et al.
Publicado: (2014)

World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
por: Bacon, David J, et al.
Publicado: (2007)

Papillomavirus from the Bench to the Clinics
por: Longatto Filho, Adhemar, et al.
Publicado: (2012)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Obesity and Erectile Dysfunction: From Bench to Clinical Implication
por: Moon, Ki Hak, et al.
Publicado: (2019)

The JAK/STAT signaling pathway: from bench to clinic
por: Hu, Xiaoyi, et al.
Publicado: (2021)

Antimalarial Work in Macedonia
Publicado: (1918)

Cannot write session to /tmp/vufind_sessions/sess_hf6l5u5se18jtnqf6fu6nfkt0b